Watson Pharmaceuticals

Forest Laboratories, moksha8 form strategic alliance for Latin America

Wednesday, October 24, 2012 10:33 AM

Forest Laboratories, an international pharmaceutical company, and moksha8, a pharmaceutical company that commercializes CNS medicines in Latin America, have entered into a broad strategic alliance that will provide Forest with a commercial footprint in Latin America and give moksha8 access to Viibryd and potentially other Forest products for the Latin American market.

More... »

Watson to acquire Actavis Group for $5.6 billion

Friday, April 27, 2012 01:02 PM

Watson Pharmaceuticals has decided to acquire privately held generics pharmaceutical company Actavis Group for an upfront payment of $5.6 billion. As a result, Watson will become the third largest global generics company with 2012 anticipated pro forma revenue of approximately $8 billion.

More... »

Watson to open New Jersey R&D center

Wednesday, February 1, 2012 03:37 PM

Watson Pharmaceuticals is planning a global R&D technology center in North Brunswick, N.J. The company has signed a lease for a 32,000-square-foot facility at the Economic Development Authority's Technology Center of New Jersey, a 50-acre complex consisting of lab, production and office space. Watson intends to initially invest approximately $4.5 million in outfitting the new facility.

More... »

Watson acquires Ascent Pharmahealth

Tuesday, January 24, 2012 02:47 PM

Parsippany, N.J.-based Watson Pharmaceuticals has acquired Ascent Pharmahealth, the Australia and Southeast Asia generic pharmaceutical business of Strides Arcolab, for $393 million in cash.

More... »

FDA committee fails to recommend gel to reduce preterm birth

Monday, January 23, 2012 01:55 PM

The FDA’s advisory committee for Reproductive Health Drugs did not recommend approval of progesterone vaginal gel 8% for the reduction of risk of preterm birth in women with short uterine cervical length at the mid-trimester of pregnancy, confirmed Columbia Laboratories and Watson Pharmaceuticals.

More... »

Amgen, Watson collaborate to develop oncology biosimiliars

Tuesday, December 20, 2011 12:44 PM

Amgen and Watson Pharmaceuticals will collaborate to develop and commercialize several oncology antibody biosimilar medicines.

More... »

North American pharma growing by overseas acquisitions

Tuesday, May 31, 2011 03:24 PM

European drugmakers have more competition for nearby buyouts these days, according to a report on FiercePharma. With North America's pharma companies turning to international markets for growth, they're scouting Central Europe, Eastern Europe, Turkey and the Middle East for potential generics deals, which is likely to push prices upward, experts told Dow Jones.

More... »

Watson to move corporate headquarters

Thursday, April 14, 2011 01:12 PM

Watson Pharmaceuticals said it will move its corporate headquarters to Parsippany, New Jersey from Corona, California, according to a Reuters report.

More... »